Intuitive Surgical (ISRG), the creator of the da Vinci robotic-assisted surgical system, reported a first-quarter profit that exceeded market consensus. The company’s flagship da Vinci surgical system continues to be a revenue driver for the instruments and accessories segment. Shares of Intuitive Surgical inched 6.10% up after the market close on Tuesday.
With total revenue jumping 25% to about $858 million, the instruments maker saw its earnings for the quarter soar 59% higher to $288 million or $2.44 per share. Foreign currency changes contributed about three percentage points to the revenue growth. A climb in the worldwide da Vinci procedures helped the total revenue spurt. Adjusted earnings per share climbed by 43%.
Global da Vinci procedures grew about 15% helped by growth in U.S. general surgery procedures and worldwide urologic procedures. The company shipped 185 da Vinci surgical systems during the quarter, up from 133 last year. The 15% growth in da Vinci procedure volume drove the instrument and accessory revenue higher by about 21%.
On recommendation trends, eleven of the eighteen analysts are expecting a “buy” or “strong buy” rating and six are predicting a “hold” rating. On the growth estimates front, the market is seeing an 8.30% growth for the current year and a 14% jump for the next year. On the shareholding front, 1.06% of shares are held by insiders, and institutions hold 91.42%.
With more than 4,400 installed systems, Intuitive Surgical dominates the robotic surgical systems market. The company invests more than 10% of revenue into research and development as known from its growth of 30% during the quarter. The company can remain on the top of the market till its R&D investments and financial strength remain strong.
On the competition front, Intuitive Surgical will face a bigger challenge from Medtronic (MDT), which intends to launch later this year its own robotic surgical system. Medtronic will release their earnings results for the fourth quarter of 2018 on May 24. Investors are expecting Medtronic to talk more about the launch of a robotic surgical system at their earnings conference.
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to